CCC's past history dictates that they cannot expect to get the respect of investors back overnight.Excluding the CEO, the best impetus would occur with a substantial change in the Board.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025